Cosmo Files Second Patent Suit Against Actavis Over Generic Uceris

Cosmo Technologies filed a second lawsuit against Actavis alleging the drugmaker infringed upon Cosmo’s patent with its newly approved generic for the colitis drug Uceris (budesonide).
Source: Drug Industry Daily